Precigen (PGEN) Long-Term Investments (2012 - 2026)
Precigen (PGEN) reported Long-Term Investments of $489000.0 for Q1 2026, down 34.8% year-over-year from $750000.0 in Q1 2025, and down 80.53% quarter-over-quarter from $2.5 million in Q4 2025.
Precigen (PGEN) Long-Term Investments (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 14 years of Long-Term Investments data on file, last reported at $489000.0 in Q1 2026.
- Long-Term Investments for Q1 2026 came in at $489000.0, down 34.8% year-over-year; the trailing twelve-month figure through Mar 2026 was $489000.0 (down 34.8% YoY), and the FY2025 annual result was $2.5 million, changed N/A from the prior year.
- Long-Term Investments retreated to $489000.0 in Q1 2026 per PGEN's latest filing, from $2.5 million in the prior quarter.
- Over five years, Long-Term Investments peaked at $29.9 million in Q1 2022 and troughed at $489000.0 in Q1 2026.
- A 4-year average of $7.5 million and a median of $5.3 million in 2023 frame the typical range for Long-Term Investments.
- The sharpest annual moves came in 2022 and 2026: Long-Term Investments sank 86.07% in 2022, then sank 34.8% in 2026.
- A 4-year view of Long-Term Investments shows it stood at $11.9 million in 2022, then sank by 55.62% to $5.3 million in 2023, then sank by 52.36% to $2.5 million in 2025, then slumped by 80.53% to $489000.0 in 2026.
- Business Quant data shows PGEN's Long-Term Investments at $489000.0 in Q1 2026, $2.5 million in Q4 2025, and $2.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 5.17 Mn |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 5.75 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Precigen | 1.58 Bn | 1.58 Bn | 20.69 Mn | 489,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 489,000.00 |
| Dec 31, 2025 | 2.51 Mn |
| Sep 30, 2025 | 2.51 Mn |
| Mar 31, 2025 | 750,000.00 |
| Sep 30, 2023 | 5.27 Mn |
| Jun 30, 2023 | 7.13 Mn |
| Mar 31, 2023 | 7.46 Mn |
| Jun 30, 2022 | 11.88 Mn |
| Mar 31, 2022 | 29.91 Mn |
| Dec 31, 2021 | 48.56 Mn |
| Sep 30, 2021 | 66.93 Mn |
| Jun 30, 2021 | 85.27 Mn |
| Mar 31, 2021 | 103.61 Mn |
| Sep 30, 2020 | 337,000.00 |
| Jun 30, 2020 | 859,000.00 |
| Mar 31, 2020 | 1.11 Mn |
| Dec 31, 2019 | 1.46 Mn |
| Sep 30, 2019 | 6.52 Mn |
| Jun 30, 2019 | 18.09 Mn |
| Mar 31, 2019 | 1.60 Mn |